The start of phase 2 Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder by Acadia has been postponed to March 1, 2024
https://classic.clinicaltrials.gov/ct2/history/NCT05999240?A=3&B=4&C=merged#StudyPageTop
Acadia, page-107
-
- There are more pages in this discussion • 819 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.31 |
Change
-0.030(0.24%) |
Mkt cap ! $1.570B | |||
| Open | High | Low | Value | Volume |
| $12.30 | $12.40 | $12.16 | $584.5K | 47.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1348 | $12.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.33 | 336 | 4 |
View Market Depth
| Last trade - 12.29pm 05/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |